Page 1 of Clinical Trials for "Gemtuzumab", 61 Total Matches
- 1RecruitingLast Updated: March 11, 2009Condition(s): Acute Myeloid Leukemia
- 2Active, not recruitingLast Updated: October 17, 2011Condition(s): Acute Myelogenous Leukemia; Myelodysplastic Syndrome
- 3RecruitingLast Updated: March 13, 2012Condition(s): Leukemia
- 4Active, not recruitingLast Updated: April 17, 2012Condition(s): Acute Myelogenous Leukemia; Myelodysplastic Syndrome
- 5TerminatedLast Updated: November 3, 2011Condition(s): Adult Acute Megakaryoblastic Leukemia (M7); Adult Acute Minimally Differentiated Myeloid Leukemia (M0); Adult Acute Monoblastic Leukemia (M5a); Adult Acute Monocytic Leukemia (M5b); Adult Acute Myeloblastic Leukemia With Maturation (M2); Adult Acute Myeloblastic Leukemia Without Maturation (M1); Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Acute Myelomonocytic Leukemia (M4); Adult Erythroleukemia (M6a); Adult Pure Erythroid Leukemia (M6b); Untreated Adult Acute Myeloid Leukemia
- 6Not yet recruitingLast Updated: April 17, 2012Condition(s): Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Acute Promyelocytic Leukemia (M3); Recurrent Adult Acute Myeloid Leukemia
- 7CompletedLast Updated: April 1, 2011Condition(s): Leukemia
- 8CompletedLast Updated: May 24, 2012Condition(s): Leukemia; Myelodysplastic Syndromes
- 9CompletedLast Updated: October 22, 2009Condition(s): Acute Myelogenous Leukemia; Myelodysplastic Syndrome; Chronic Lymphocytic Leukemia
- 10RecruitingLast Updated: April 28, 2011Condition(s): Acute Myeloid Leukemia
- 11TerminatedLast Updated: October 25, 2010Condition(s): Leukemia
- 12RecruitingLast Updated: October 13, 2011Condition(s): Acute Myeloid Leukemia
- 13Active, not recruiting
- 14TerminatedLast Updated: October 25, 2011Condition(s): Acute Myeloid Leukemia; Juvenile Myelomonocytic Leukemia; Myelodysplastic Syndrome
- 15Not yet recruitingLast Updated: December 24, 2009Condition(s): Acute Myeloid Leukemia
- 16Active, not recruitingLast Updated: May 22, 2012Condition(s): Leukemia
- 17Active, not recruitingLast Updated: March 21, 2012Condition(s): Acute Myeloid Leukemia
- 18Active, not recruitingLast Updated: January 10, 2011Condition(s): Acute Myeloid Leukemia
- 19Active, not recruitingLast Updated: November 13, 2010Condition(s): Leukemia
- 20CompletedLast Updated: May 17, 2006Condition(s): Acute Myelogenous Leukemia
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?intr=%22Gemtuzumab%22
